SCHEMBL7963703

SCHEMBL7963703

OC1(c2cc(C(F)(F)F)ccc2Cl)CCN(CCCc2nnc3n2CCCCC3)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.41
OPRM1 P35372 3/20 0.40
DRD2 P14416 3/20 0.40
HTR1A P08908 3/20 0.40
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
DRD4 P21917 2/20 0.40
HRH2 P25021 2/20 0.40
HTR1D P28221 2/20 0.40
HTR7 P34969 2/20 0.40
OPRK1 P41145 2/20 0.40
HRH1 P35367 1/20 0.40
OPRL1 P41146 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.39
SHMT2 P34897 1/20 0.39
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37
SLC6A4 P31645 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957105 0.84 DRD2 (0.46) HSD11B1DRD2HTR1AHTR2AHTR2C
SCHEMBL7957541 0.84 OPRM1 (0.58) OPRM1DRD2HTR1AHTR2AHTR2C
SCHEMBL7963844 0.81 LMNA (0.45) HSD11B1DRD2HTR1AHTR2AHTR2C
SCHEMBL7959210 0.81 DRD2 (0.45) OPRM1DRD2HTR1AHTR2AHTR2C
SCHEMBL7959533 0.81 DRD2 (0.48) HSD11B1DRD2HTR1AHTR2AHTR2C
SCHEMBL7959113 0.80 L3MBTL1 (0.41) HSD11B1HTR1AHTR2AHTR2CL3MBTL1
SCHEMBL7957371 0.79 LMNA (0.52) HSD11B1OPRM1DRD2HTR1AHTR2A
SCHEMBL7960165 0.79 PKM (0.52) HSD11B1DRD2HTR1AHTR2AHTR2C
SCHEMBL7959708 0.78 DRD2 (0.55) HSD11B1OPRM1DRD2HTR1AHTR2A
SCHEMBL7963975 0.77 L3MBTL1 (0.39) HSD11B1HTR1AHTR2AHTR2CL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed